telmisartan
Micardis · ATC code C09CA07
Brand names: Micardis, Actelsar, Telmicard, Telmisartan Ratiopharm, Telmisartan Sandoz, Telmisartan Stada, Micator, Qualtan, Telmiday Plus, Telmitek, Telvis, Telzap, Tenvia Plus, Uloxetic
- Key facts
- Active substance
- telmisartan
- ATC code
- C09CA07
- Authorisation
- centrally authorised across the EU (EMA)
- Dosage forms
- Micardis 20 mg tablets / Micardis 40 mg tablets / Micardis 80 mg tablets
- Marketing authorisation holder
- Boehringer Ingelheim International GmbH
- Information as of
- 2026-10-27
Key facts
Telmisartan (Micardis) is an angiotensin II receptor blocker for essential hypertension and for reduction of cardiovascular morbidity in high-risk adults.
What it is used for
- Essential hypertension in adults
- Reduction of cardiovascular morbidity in manifest atherothrombotic disease (coronary heart disease, stroke, peripheral arterial disease) or type 2 diabetes with target organ damage
Dosing
- Hypertension: usually 40 mg once daily; some patients benefit from 20 mg; maximum 80 mg once daily
- Maximum antihypertensive effect generally 4 to 8 weeks after starting
- Cardiovascular prevention: 80 mg once daily; monitor blood pressure closely at initiation
- Severe renal impairment or haemodialysis: lower starting dose of 20 mg
- Mild to moderate hepatic impairment: no more than 40 mg once daily
Contraindications
- Hypersensitivity to the active substance or any excipient
- Second and third trimesters of pregnancy
- Biliary obstructive disorders and severe hepatic impairment
- Aliskiren in patients with diabetes or renal impairment (GFR < 60)
Important warnings
- Stop immediately when pregnancy is diagnosed
- Renal artery stenosis: increased risk of severe hypotension and renal insufficiency
- Renal impairment: periodic monitoring of potassium and creatinine
- Dual RAAS blockade not recommended
Side effects
- Overall incidence comparable to placebo
- Uncommon: urinary and upper respiratory tract infections, anaemia, hyperkalaemia
- Rare serious: anaphylactic reaction, angioedema; also acute renal failure, sepsis
Interactions
- Digoxin: increased levels; monitor digoxin when starting, adjusting or stopping telmisartan
- Potassium-sparing diuretics, potassium salt substitutes, ACE inhibitors, NSAIDs, heparin, cyclosporin, tacrolimus, trimethoprim: hyperkalaemia risk
- Lithium: increased levels and toxicity possible; monitor levels
- NSAIDs: reduced antihypertensive effect and risk to renal function
Pregnancy and breastfeeding
- Not recommended in the first trimester; contraindicated in the second and third trimesters
Summary of the official product information, written with AI (Claude, Anthropic) on 2026-10-28. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.
Common questions – ask Medelix
For patients
Package leaflet, verbatim
Authorisation and brand names by country
Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.
EU – centrally authorised (all member states)
- MicardisBoehringer Ingelheim International GmbH · EMEA/H/C/000209
- Telmisartan Actavis · genericActavis Group PTC ehf · EMEA/H/C/001168
- Telmisartan Teva Pharma · genericTeva B.V. · EMEA/H/C/002511
- Tolura · genericKrka, d.d., Novo mesto · EMEA/H/C/001196
Source: European Medicines Agency (EMA), product information
Austria
- ActelsarActavis Group Ptc Ehf. · 1 register entry
- TelmicardG.L. Pharma Gmbh · 1 register entry
- Telmisartan RatiopharmTeva B.V · 1 register entry
- Telmisartan SandozSandoz Gmbh · 1 register entry
- Telmisartan StadaStada Arzneimittel Gmbh · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Germany
- Telmisartan1 A Pharma Gmbh, Micro Labs Gmbh, Ratiopharm Gmbh, Medical Valley Invest Ab, Glenmark Arzneimittel Gmbh, Heumann Pharma Gmbh & Co. Generica Kg, Zentiva Pharma Gmbh, Hexal Ag, Puren Pharma Gmbh & Co. Kg, Stadapharm Gmbh, Abz-Pharma Gmbh, Aliud Pharma Gmbh · 12 register entries
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Turkey
- MicardisBOEHRİNGER INGELHEİM İLAÇ TİC. A.Ş. · 3 register entries
- MicatorHUMANİS SAĞLIK A.Ş. · 5 register entries
- QualtanBERKO İLAÇ VE KİMYA SAN. A.Ş. · 2 register entries
- Telmiday PlusNUVOMED İLAÇ SAN.TİC. A.Ş. · 6 register entries
- TelmitekNOBEL İLAÇ PAZARLAMA VE SAN. LTD. ŞTİ. · 3 register entries
- TelvisNEUTEC İLAÇ SAN. TİC. A.Ş · 9 register entries
- TelzapSANOFİ İLAÇ SAN. VE TİC. A.Ş. · 4 register entries
- Tenvia PlusCELTİS İLAÇ SAN. TİC. A.Ş. · 6 register entries
- UloxeticWORLD MEDICINE İLAÇ SAN. VE TİC. A.Ş. · 4 register entries
Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16
Brand names in 24 more European countries
- Belgium
- Telmisartan Eg, Telmisartan Teva, Telmisartan Viatris
- Bulgaria
- Telsart, Tезео, Актелсар, Танидон, Телмисартан Стада, Телмитан Sopharma Ad
- Cyprus
- Telmisartan Jubilant
- Czechia
- Telmisartan Egis, Telmisartan Ratiopharm, Telmisartan Sandoz, Tezeo
- Denmark
- Telmisartan Medical Valley, Telmisartan Stada, Zanacodar
- Estonia
- Telmisartaan Amarox, Telmisartan Ratiopharm, Telmisartan Sandoz
- Finland
- Telmark, Telmisartan Amarox, Telmisartan Orion, Telmisartan Ratiopharm, Telmisartan Sandoz, Telmisartan Stada
- France
- Telmisartan Amarox, Telmisartan Arrow, Telmisartan Biogaran, Telmisartan Cristers, Telmisartan Eg, Telmisartan Sandoz, Telmisartan Teva Sante, Telmisartan Viatris, Telmisartan Zentiva, Telmisartan Zydus
- Hungary
- Tanydon, Telmisartan Egis, Telmisartan Ratiopharm, Telmizartán Amarox, Tezeo
- Iceland
- Kinzalmono, Micardis, Pritor, Telmisartan Actavis, Tolura
- Ireland
- Mirpresoc, Telmisartan Accord Healthcare Ireland, Telmisartan Amarox, Telmisartan Brillpharma (Ireland), Telmisartan Clonmel, Telmisartan Fair-Med, Telmisartan Rowa
- Italy
- Telmisartan Almus, Telmisartan Alter, Telmisartan Aurobindo, Telmisartan Doc Generici, Telmisartan Eg, Telmisartan Mylan, Telmisartan Pensa, Telmisartan Sandoz, Telmisartan Teva Italia, Telmisartan Zentiva
- Latvia
- Telmisartan Ratiopharm, Tezeo
- Liechtenstein
- Kinzalmono, Micardis, Pritor, Telmisartan Actavis
- Lithuania
- Telmisartan Ingen Pharma, Telmisartan Inteli, Telmisartan Ratiopharm, Tezeo
- Luxembourg
- Telmisartan Eg, Telmisartan Micro Labs, Telmisartan Ratiopharm, Telmisartan Viatris
- Netherlands
- Telmisartan
- Norway
- Kinzalmono, Micardis, Pritor, Telmisartan Actavis, Tolura
- Poland
- Actelsar, Polsart, Telmabax, Telmisartan Aurovitas, Telmisartan Bluefish, Telmisartan Egis, Telmisartan Genoptim, Telmisartan Medical Valley, Telmisartan Orion, Telmix, Telmizek, Tezeo, Toptelmi, Zanacodar
- Portugal
- Diterpris, Mirpresoc, Telmisartan Alter Genéricos, Telmisartan Aurobindo, Telmisartan Azevedos, Telmisartan Basi, Telmisartan Bluefish, Telmisartan Ciclum, Telmisartan Evertine, Telmisartan Farmoz, Telmisartan Generis Phar, Telmisartan Ipca, Telmisartan Liconsa, Telmisartan Mylan, Telmisartan Phar Generis Phar, Telmisartan Pharmakern, Telmisartan Ratiopharm, Telmisartan Sandoz, Telmisartan Tecnigen, Telmisartan Tolife, Telmisartan Zentiva, Tesgreco, Zanacodar
- Romania
- Tezeo
- Slovakia
- Telmark, Telmisartan Egis, Telmisartan Sandoz, Tezeo
- Spain
- Telmark, Telmisartan Teva-Ratiopharm, Telmisartán Almus, Telmisartán Alter, Telmisartán Aurovitas, Telmisartán Cinfa, Telmisartán Combix, Telmisartán Kern Pharma, Telmisartán Normon, Telmisartán Pensa, Telmisartán Sandoz, Telmisartán Stada, Telmisartán Tarbis, Telmisartán Tecnigen, Telmisartán Teva-Ratiopharm, Telmisartán Viatris, Telmisartán Vir
- Sweden
- Telmark, Telmisartan Amarox, Telmisartan Jubilant, Telmisartan Stada
EMA – Article 57 product data (EU/EEA), 2026-10-28
Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.
Other substances in the same group
Related calculators
Another question about this substance?
Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.
Sources
- European Medicines Agency. Micardis – EPAR, Product Information (OF THE TEXT Detailed information on this medicinal product i). 2026-10-27. https://www.ema.europa.eu/en/documents/product-information/micardis-epar-product-information_en.pdf
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
Editorial: Medelix editorial team · last updated 2026-10-27 · How these pages are made · Report an error
Source: European Medicines Agency (EMA), product information. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.